| Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab (NCT02719613) | Bristol-Myers Squibb | 2016-07-15 |
| TOL-463 Phase 2 Study for Vaginitis (NCT02866227) | Toltec Pharmaceuticals, LLC | 2016-07-15 |
| Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NCT02603406) | Ajou University School of Medicine | 2016-07-15 |
| Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis (NCT02844777) | Vidac Pharma | 2016-07-15 |
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer (NCT02827877) | City of Hope Medical Center | 2016-07-15 |
| Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma (NCT02724878) | Dana-Farber Cancer Institute | 2016-07-15 |
| Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation (NCT02790515) | St. Jude Children's Research Hospital | 2016-07-14 |
| A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males (NCT02781311) | Allergan | 2016-07-14 |
| Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI) (NCT02743949) | Takeda | 2016-07-14 |
| Effect of Levobupivacaine Infiltration on the Post Partum Perineal Pain in Episiotomy, in Primiparous Women After Instrumental Delivery (NCT02796547) | Brugmann University Hospital | 2016-07-14 |
| Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC) (NCT02753595) | Eisai Inc. | 2016-07-13 |
| A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer (NCT02632305) | AHS Cancer Control Alberta | 2016-07-13 |
| Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT02836418) | aTyr Pharma, Inc. | 2016-07-13 |
| Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction (NCT03355963) | Benha University | 2016-07-12 |
| FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial (NCT02578732) | Brown University | 2016-07-12 |
| An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg) (NCT02856802) | Upsher-Smith Laboratories | 2016-07-11 |
| Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product (NCT02933502) | Sun Pharmaceutical Industries, Inc. | 2016-07-11 |
| Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS (NCT02933528) | Sun Pharmaceutical Industries, Inc. | 2016-07-11 |
| Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer (NCT02657928) | Mayo Clinic | 2016-07-08 |
| Smoking Cessation & Opioid Dependence Treatment Integration (NCT02854800) | West Virginia University | 2016-07-08 |
| Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases (NCT02800551) | University of Zurich | 2016-07-08 |
| Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone Lymphoma (NCT03093831) | National Cancer Centre, Singapore | 2016-07-08 |
| Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults (NCT02788045) | Janssen Vaccines & Prevention B.V. | 2016-07-08 |
| A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma (NCT02699606) | Janssen Research & Development, LLC | 2016-07-08 |
| A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age (NCT02719743) | GlaxoSmithKline | 2016-07-07 |
| A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC) (NCT02657369) | Eisai Inc. | 2016-07-07 |
| Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia (NCT02756897) | M.D. Anderson Cancer Center | 2016-07-07 |
| A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma (NCT02807454) | Celgene | 2016-07-07 |
| Daratumumab in Combination With ATRA (NCT02751255) | Amsterdam UMC, location VUmc | 2016-07-06 |
| Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck (NCT02769520) | Assuntina G. Sacco, MD | 2016-07-06 |
| Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) (NCT02726997) | M.D. Anderson Cancer Center | 2016-07-06 |
| A Study of Modified Stem Cells in Traumatic Brain Injury (TBI) (NCT02416492) | SanBio, Inc. | 2016-07-06 |
| Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors (NCT02738502) | ANRS, Emerging Infectious Diseases | 2016-07-06 |
| Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults (NCT01887522) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-07-06 |
| A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL) (NCT02801578) | M.D. Anderson Cancer Center | 2016-07-06 |
| BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients (NCT02650804) | BPGbio | 2016-07-06 |
| Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance (NCT02756962) | Washington University School of Medicine | 2016-07-06 |
| A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) (NCT02821754) | National Cancer Institute (NCI) | 2016-07-05 |
| Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA (NCT02806895) | Jazz Pharmaceuticals | 2016-07-05 |
| Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2] (NCT02780700) | Boehringer Ingelheim | 2016-07-05 |
| A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome (NCT02701985) | Hoffmann-La Roche | 2016-07-05 |
| Obinutuzumab in Combination With Ibrutinib in Treating Patients With Relapsed Mantle Cell Lymphoma (NCT02736617) | OHSU Knight Cancer Institute | 2016-07-05 |
| Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02520154) | M.D. Anderson Cancer Center | 2016-07-05 |
| Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease (NCT02850406) | Pfizer | 2016-07-05 |
| High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma (NCT02597062) | Canadian Cancer Trials Group | 2016-07-05 |
| Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma (NCT02631590) | H. Lee Moffitt Cancer Center and Research Institute | 2016-07-05 |
| Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer (NCT03729687) | Uppsala University | 2016-07-04 |
| MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD (NCT02876172) | Resilient Pharmaceuticals | 2016-07-03 |
| Cell Therapy by Autologous BMC for Large Bone Defect Repair (NCT02803177) | Goethe University | 2016-07-02 |
| Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents (NCT03981861) | Children's Mercy Hospital Kansas City | 2016-07-02 |
| Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent. (NCT03031028) | Tehran University of Medical Sciences | 2016-07-01 |
| Comparison Between IV Propofol and Propofol/ Fentanyl Anesthesia on Patients Stress Response (NCT03143933) | Cairo University | 2016-07-01 |
| PGE1 as Additive Anticoagulant in ECMO-Therapy (NCT02895373) | Thomas Staudinger | 2016-07-01 |
| Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K (NCT02870829) | National University Health System, Singapore | 2016-07-01 |
| Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease (NCT02382198) | Ottawa Hospital Research Institute | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer (NCT02843815) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease (NCT02831387) | Parion Sciences | 2016-07-01 |
| Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma (NCT02656706) | Brown University | 2016-07-01 |
| Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors (NCT02843204) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| MLE4901 vs. Placebo for the Treatment of PCOS (NCT02865915) | Millendo Therapeutics US, Inc. | 2016-07-01 |
| Double Ligation and Topical Silver Nitrate (NCT04248101) | Shaheed Zulfiqar Ali Bhutto Medical University | 2016-07-01 |
| G-CSF and Autologous Cord Blood Infusion in Cerebral Palsy (NCT02866331) | Hanyang University Seoul Hospital | 2016-07-01 |
| The Effects of Trichosanthes Root on Blood Sugar in Patients With Diabetes Mellitus (NCT02855645) | China Medical University Hospital | 2016-07-01 |
| Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma (NCT02851589) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-07-01 |
| Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction (NCT02837939) | Martin Janičko | 2016-07-01 |
| Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney (NCT02613819) | Trans Tasman Radiation Oncology Group | 2016-07-01 |
| A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer (NCT02844699) | Panacela Labs LLC | 2016-07-01 |
| Senescence in Chronic Kidney Disease (NCT02848131) | Mayo Clinic | 2016-07-01 |
| Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer (NCT02849340) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) (NCT02767063) | Versailles Hospital | 2016-07-01 |
| Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer (NCT03273595) | Xijing Hospital | 2016-07-01 |
| Ubiquinol Treatment in Patients With Heart Failure and Preserved Ejection Fraction (NCT02779634) | Hadassah Medical Organization | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer (NCT02844335) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia (NCT02864654) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2016-07-01 |
| Combination of Rituximab and NK Immunotherapy for B Lymphoma (NCT02843061) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| DLBS1449 in Diabetic Patients With Low HDL (NCT01972477) | Dexa Medica Group | 2016-07-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199) (NCT02787005) | Merck Sharp & Dohme LLC | 2016-07-01 |
| Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors (NCT02691078) | Latin American Cooperative Oncology Group | 2016-07-01 |
| Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers (NCT02751359) | University of California, Los Angeles | 2016-07-01 |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer (NCT02843607) | Fuda Cancer Hospital, Guangzhou | 2016-07-01 |
| Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations (NCT02674750) | Curis, Inc. | 2016-07-01 |
| Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain (NCT02729207) | Teikoku Seiyaku Co., Ltd. | 2016-07-01 |
| A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder (NCT03291041) | Vanda Pharmaceuticals | 2016-07-01 |
| Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects (NCT03034408) | Prof. Daniele Zullino | 2016-07-01 |
| A Trial of PF-06252616 in Ambulatory Participants With LGMD2I (NCT02841267) | Kathryn Wagner | 2016-07-01 |
| Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section (NCT03098420) | University of Alabama at Birmingham | 2016-07-01 |
| Effects of Photobiomodulation in Salivary Analysis of Chronic Renal Failure Patients (NCT03647813) | University of Nove de Julho | 2016-07-01 |
| A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus (NCT02744898) | NYU Langone Health | 2016-07-01 |
| Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer (NCT02792842) | Asahi Kasei Therapeutics Corporation | 2016-07-01 |
| Efficacy of Gaviscon-Advance® in Suppressing Post-supper Acid-pocket and Night-time Acid-reflux in Obese Participants (NCT03516188) | Universiti Sains Malaysia | 2016-07-01 |
| Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. (NCT02806414) | University of California, San Diego | 2016-07-01 |
| Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients (NCT02904031) | Gruppo Oncologico del Nord-Ovest | 2016-07-01 |
| Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene (NCT02885766) | Fusion Pharma LLC | 2016-07-01 |
| Maternal Tdap Immunization in Guatemala (NCT02301702) | Emory University | 2016-07-01 |
| Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study (NCT02810015) | University of Manitoba | 2016-07-01 |
| Fecal Microbiota Transplantation for Ulcerative Colitis (NCT03016780) | First Affiliated Hospital of Chengdu Medical College | 2016-07-01 |
| A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects (NCT03268083) | Enimmune Corporation | 2016-07-01 |
| Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis (NCT02804191) | Ocuwize LTD | 2016-07-01 |
| Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma (NCT02836847) | Shanghai Jiao Tong University School of Medicine | 2016-07-01 |
| Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium (NCT02782260) | Ariel University | 2016-07-01 |